spacer
home > pmps > Summer 2009
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Summer 2009

Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision-makers within the industry, identifying new trends and marketing opportunities as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharmaceutical, biotech, nutritional and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.

   
Text
PDF
bullet
Manufacturing
The management of processes which span the supply chain presents a considerable challenge to pharmaceutical executives. Stefano Bergantino at Accenture proposes enterprise resource planning as a means by which meeting these challenges can be facilitated.  
view
download pdf
The manufacture of drugs typically follows a stepwise process. While this makes the preparation of new drugs easier, it may preclude innovation and improvement. Adrian Howson at Sagentia Limited introduces continuous processing as the forward for manufacturing.  
view
download pdf

Reactors used in pharmaceutical manufacturing must be durable in order to withstand the chemical recations which take place inside them, and to meet FDA and GMP requirements. Kerry Clunie at Pfaudler Balfour investigates how glass-lined reactors can offer this benefit, while also being conveniently lightweight.

 
view
download pdf
Many drug manufacturing cycles use lyophilisation at some stage, but may not be doing so efficiently. Jorge Sassone at Improvement-Proquimo do Brazil, Enric Jo and Laura Noguera at Reig Jofre Group, and JR Mullick at Klenzaids discuss how the full benefit can be derived from the lyophilisation process.  
view
download pdf
Pharma is not known for its ability to learn from other industries, and this is holding the sector back, claims Paul Beaumont at WCI Consulting, who goes on to outline the benefits that could be gained from a more open approach in this area.  
view
download pdf
bullet
Cool Chain, Cargo & Logistics
The globalisation of the pharmaceutical supply chain has seen an increasing demand on air cargo as a means of cold chain shipping. Mark Mohr at Continental Airlines Cargo suggests that this change in demand has helped to accelerate the evolution of the air cargo industry as a whole.  
view
download pdf
Another industry sector which has had to adapt to serve the demands of the pharmaceutical industry is road transportation, but now it is time to look beyond the provision of temperature-controlled vehicles, argues Jason Breakwell at Rutges Cargo.  
view
download pdf
One of the options open to companies seeking to distribute products via road is the pallet network - the ideal solution in the current climate, asserts Craig Hibbert of Palletways' UK Member Network.  
view
download pdf
Security is a prerequisite in the distribution of drugs; Mark Beauchamp at Citizen Systems looks at how labelling technology can safeguard pharmaceuticals on their journey through the supply chain.  
view
download pdf
bullet
Drug Delivery 
Since the introduction of the first mechanical spray pump for nasal drug delivery in the early 1970s, such devices have undergone constant improvement. Hervé Pacaud at Valois Pharma identifies patient-independent features as the next step towards the paradigm of the fully compliant device.  
view
download pdf
Mark Copley at Copley Scientific provides an overview of the benefits of pulmonary drug delivery, and of advances in the development of inhaled drug delivery systems.  
view
download pdf
bullet
Formulations, Ingredients and Excipients
Adrian Possumato at Multisorb Technologies explores how pseudo-empirical modelling can be used to investigate the relationship between drug formulations and their packaging environment.  
view
download pdf

Maxime Laugier at MP5 outlines the challenges facing formulation scientists developing injectable biopharmaceuticals, and guides us through the ways in which they can be overcome.

 
view
download pdf
bullet
PACKING, PACKAGING & ANTI-COUNTERFEITING

The EU BRIDGE project seeks to develop a complete item-level traceability system for the pharmaceutical supply chain. John Jenkins at JJ Associates introduces the project, and explains how it will benefit the industry as a whole.

 
view
download pdf
The sheer size of the pharmaceutical market and the advent of the internet mean that the absolute prevention of counterfeit drug sales is now impossible, but, says Philip Payne at RSSL Pharma, each party involved along the line should do their best to crack down on the problem.  
view
download pdf
Advanced technology and a well-developed security stratey are key weapons in the war against counterfeits. Loius M Parks at SecureRF Corporation describes how the two can work together to provide the highest level of protection.  
view
download pdf
Blisterpacks are an example of a packaging type which demands specialised security features. Cathy Brown at Napp Pharmaceuticals Limited identifies these features, and explains what else can be done to ensure the safety of blisterpacks.  
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

Amcor partners with Moda to offer innovative packaging solutions

Amcor is pleased to announce its partnership with Moda vacuum packaging systems in North America and Latin America. By combining Amcor’s shrink bag and rollstock film for meat and cheese with Moda’s system, producers can gain operational efficiencies and drive total cost savings.
More info >>

White Papers

The Power of Execution in Clinical Research

Medpace

Medpace, long known for its excellence in conducting Phase I-IV studies on a global platform, is particularly noted for its therapeutic excellence. When that expertise is combined with operational precision, the results are nothing short of stellar. The Medpace full-service outsourcing approach – combined with therapeutic expertise, regulatory know how, and global presence – delivers clinical studies with an industry recognized track record.
More info >>

Industry Events

SMi Presents the 4th Annual: Highly Potent Active Pharmaceutical Ingredients (HPAPI)

11-13 May 2020, Copthorne Tara Hotel, London, UK

SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020. HPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement